Contakt World Announces Research, Development and Training (RDT) Division and Retention of Expert Grant Consultants FreeMind Group



*Contakt World to Seek Recurring, Non-Dilutive Capital through Grants*

*VANCOUVER, BC / ACCESSWIRE / January 19, 2021 /* Tracker Ventures Corp. ("*Tracker*" or the "*Company*") (CSE:TKR)(OTC PINK:TLOOF)(FWB:B2I) today announced that Contakt LLC ("*Contakt World*"), a technology company modernizing public health and safety, has launched its Research, Development, Training division (the "*RDT division*") to spearhead continued development of breakthrough public health and safety technologies by conducting university research and by seeking funding through non-dilutive grants.

The RDT division is expected to play a critical role in non-dilutive capital formation for Contakt World through recurring applications for grants bolstered by the expertise and scale of the FreeMind Group ("*FreeMind*"), which has successfully garnered over $1.5 billion USD in awards for its clients. FreeMind will assist Contakt World with strategy and frequent applications from agencies in the United States such as National Institutes of Health (NIH), Department of Defense (DoD), Biomedical Advanced Research Development Authority (BARDA), National Science Foundation (NSF) and through private foundations.

Through academic research partnerships, internal consultations, its engagement of FreeMind and internal and external training programs, the RDT division will support Contact World's goal to connect health agencies with their communities. Leveraging FreeMind's expertise, the RDT division is expected to fund commercial deployment of Contakt World solutions to under-resourced local health agencies, identify gaps that exist in public health agency technologies, improve existing solutions and develop new solutions that improve public health and safety for a mid- and post-pandemic world.

Key priorities for the RDT division include:

· Establishing multiple academic research partnerships to create a pipeline of meaningful research to study vulnerable populations and disruptive innovation for public health. Initial research involving Contakt World commenced at the Sue and Bill Gross School of Nursing and University of California, Irvine in 2020, recently expanding to Franciscan Missionaries of Our Lady University (FranU) in Louisiana, and Augusta University in Georgia;

· Developing grant programs that fund Contakt World to deploy its solutions in under-resourced health agencies, including but not limited to the approximately 2,000 local health agencies in the United States which presently serve populations of less than 50,000; and

· Creating internal and external training and education modules to support deployment and enhance scalability of Contakt World's public health and safety technologies, including its contact tracing platform and community messaging solutions.

"The RDT division demonstrates Contakt World's commitment to health equity, serving vulnerable populations and innovation in public health, which has been historically under-resourced and underappreciated," said Riaz Ferdaus, PhD. MBBS, VP of Research, Contakt World. "We hope that our programs, which are specifically guided or driven by meaningful academic research and affiliations with leading associations like the National Association of County and City Health Officials, will improve contact tracing, trust in vaccines and health agency resources. With our recent retention of FreeMind, we hope to financially support our programs with non-dilutive capital through grants and further establish Contakt World as an industry leader in public health and safety."

*Contakt World - Tracker Transaction*

Tracker and Contakt World are parties to a definitive amalgamation agreement pursuant to which Tracker will indirectly acquire (the "*Acquisition*") a 100% interest in Contakt World. For further information respecting the Acquisition, please refer to the Company's news release dated December 8, 2020. Trading of Tracker's shares on the Canadian Securities Exchange (the "*CSE*") has been halted in connection with the announcement of the Acquisition and is not expected to resume until the CSE has approved a Form 2A Listing Statement for the resulting issuer from the Acquisition. There can be no assurance that the Acquisition will be completed on the terms proposed in the amalgamation agreement or at all.

*About Contakt World*

Contakt World is a technology and media company innovating public health agency connections with their community, with the goal of becoming the most trustworthy, accessible and scalable digital public health and safety platform globally - addressing the needs of a post-pandemic world. Contakt World combines aggressive research and development, human-centered design, next-gen data integrations, and strategic health partnerships to empower and build mutual trust within communities, contributing towards health equity for users around the world. Contakt World's first suite of tools emerge from the urgency surrounding coronavirus to manage the pandemic through innovative contact tracing and case management spanning multiple modes of communication. For more information, please visit the Company's website at

*Tracker Ventures Contact *
Geoff Balderson
CEO and Director
Direct: 604-602-0001

*Media Contact*
Kevin Harrington
Account Director - 5WPR

*Investor Contact*
Lucas A. Zimmerman
Senior Vice President - MZ North America
Direct: 949-259-4987

The CSE has not reviewed, approved or disapproved the content of this news release.

*Forward Looking Statements Disclaimer*

This press release contains "forward-looking information" within the meaning of applicable securities laws ("*forward-looking statements*"), including, but not limited to, statements with respect to the future prospects of Tracker and Contakt World. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "projects", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements, including statements respecting: the RDT division, its goals and its expected ability to establish partnership, secure additional grants and funding, enhance the Contakt World platform and other offerings and further establish Contakt World as an industry leader in public health and safety; and Contakt World's hope that its programs will improve contact tracing, trust in vaccines and health agency resources. Although forward-looking statements contained in this press release are based upon what management of Tracker and Contakt World believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include those risks listed above as well as additional risks like regulatory changes, general economic, market, political, or business conditions, actual or perceived implications of COVID-19 immunization or treatments and the timing and delivery thereof, meeting or maintaining various conditions of HIPAA, GDPR, and CCPA compliance, protection of the Company's and Contakt World's intellectual property, and adoption of the Contakt World platform or apps by government, B2B, B2I customers and consumer end-users. Tracker and Contakt World undertake no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

*SOURCE:* Tracker Ventures Corp.
View source version on

Full Article